Чланци са овлашћеним јавним приступом - Luca AntonioliСазнајте више
Није доступно нигде: 7
Adenosine and inflammation: what's new on the horizon?
L Antonioli, B Csóka, M Fornai, R Colucci, E Kokai, C Blandizzi, G Haskó
Drug Discovery Today 19 (8), 1051-1068, 2014
Овлашћења: US National Institutes of Health, Hungarian Scientific Research Fund
Switching off CD73: a way to boost the activity of conventional and targeted antineoplastic therapies
L Antonioli, SV Novitskiy, KF Sachsenmeier, M Fornai, C Blandizzi, ...
Drug discovery today 22 (11), 1686-1696, 2017
Овлашћења: US National Institutes of Health
The role of P2Y receptors in regulating immunity and metabolism
M Lovászi, CB Haas, L Antonioli, P Pacher, G Haskó
Biochemical pharmacology 187, 114419, 2021
Овлашћења: US National Institutes of Health
Adenosine and inflammation: it's time to (re) solve the problem
L Antonioli, P Pacher, G Haskó
Trends in Pharmacological Sciences 43 (1), 43-55, 2022
Овлашћења: US National Institutes of Health
Effects of L-DOPA/benserazide co-treatment on colonic excitatory cholinergic motility and enteric inflammation following dopaminergic nigrostriatal neurodegeneration
C Pellegrini, L Antonioli, R Colucci, E Tirotta, D Gentile, C Ippolito, ...
Neuropharmacology 123, 22-33, 2017
Овлашћења: Government of Italy
The pharmacological blockade of P2X4 receptor as a viable approach to manage visceral pain in a rat model of colitis
C Di Salvo, V D’Antongiovanni, L Benvenuti, M Fornai, G Valdiserra, ...
Journal of Drug Targeting 32 (8), 953-963, 2024
Овлашћења: European Commission
Pharmacological modulation of P2X4 in inflammatory bowel diseases: the way towards novel therapeutics?
V D’Antongiovanni, C Pellegrini, M Fornai, ZH Nemeth, G Haskó, ...
Journal of Drug Targeting 31 (7), 693-699, 2023
Овлашћења: US National Institutes of Health, European Commission
Доступно негде: 37
CD39 and CD73 in immunity and inflammation
L Antonioli, P Pacher, ES Vizi, G Haskó
Trends in molecular medicine 19 (6), 355-367, 2013
Овлашћења: US National Institutes of Health
Immunity, inflammation and cancer: a leading role for adenosine
L Antonioli, C Blandizzi, P Pacher, G Haskó
Nature Reviews Cancer 13 (12), 842-857, 2013
Овлашћења: US National Institutes of Health, Hungarian Scientific Research Fund
Anti-CD73 in cancer immunotherapy: awakening new opportunities
L Antonioli, GG Yegutkin, P Pacher, C Blandizzi, G Haskó
Trends in cancer 2 (2), 95-109, 2016
Овлашћења: US National Institutes of Health
Canonical and non-canonical activation of NLRP3 inflammasome at the crossroad between immune tolerance and intestinal inflammation
C Pellegrini, L Antonioli, G Lopez-Castejon, C Blandizzi, M Fornai
Frontiers in immunology 8, 36, 2017
Овлашћења: Wellcome Trust
Adenosine signalling in diabetes mellitus—pathophysiology and therapeutic considerations
L Antonioli, C Blandizzi, B Csóka, P Pacher, G Haskó
Nature reviews endocrinology 11 (4), 228-241, 2015
Овлашћења: US National Institutes of Health
Development of an acrylate derivative targeting the NLRP3 inflammasome for the treatment of inflammatory bowel disease
M Cocco, C Pellegrini, H Martínez-Banaclocha, M Giorgis, E Marini, ...
Journal of Medicinal Chemistry 60 (9), 3656-3671, 2017
Овлашћења: European Commission, Government of Spain
The purinergic system as a pharmacological target for the treatment of immune-mediated inflammatory diseases
L Antonioli, C Blandizzi, P Pacher, G Haskó
Pharmacological reviews 71 (3), 345-382, 2019
Овлашћења: US National Institutes of Health
Extracellular ATP protects against sepsis through macrophage P2X7 purinergic receptors by enhancing intracellular bacterial killing
B Csóka, ZH Németh, G Törő, M Idzko, A Zech, B Koscsó, Z Spolarics, ...
The FASEB Journal 29 (9), 3626, 2015
Овлашћења: US National Institutes of Health, Hungarian Scientific Research Fund
Alteration of colonic excitatory tachykininergic motility and enteric inflammation following dopaminergic nigrostriatal neurodegeneration
C Pellegrini, M Fornai, R Colucci, E Tirotta, F Blandini, G Levandis, ...
Journal of neuroinflammation 13, 1-13, 2016
Овлашћења: Government of Italy
Adenosine metabolism, immunity and joint health
G Haskó, L Antonioli, BN Cronstein
Biochemical pharmacology 151, 307-313, 2018
Овлашћења: US National Institutes of Health
Constipation, deficit in colon contractions and alpha-synuclein inclusions within the colon precede motor abnormalities and neurodegeneration in the central nervous system in a …
L Rota, C Pellegrini, L Benvenuti, L Antonioli, M Fornai, C Blandizzi, ...
Translational neurodegeneration 8, 1-15, 2019
Овлашћења: Government of Italy
Roles and modalities of ectonucleotidases in remodeling the multiple myeloma niche
A Chillemi, V Quarona, L Antonioli, D Ferrari, AL Horenstein, F Malavasi
Frontiers in Immunology 8, 305, 2017
Овлашћења: Government of Italy
Enteric dysfunctions in experimental Parkinson’s disease: alterations of excitatory cholinergic neurotransmission regulating colonic motility in rats
M Fornai, C Pellegrini, L Antonioli, C Segnani, C Ippolito, E Barocelli, ...
The Journal of pharmacology and experimental therapeutics 356 (2), 434-444, 2016
Овлашћења: Government of Italy
Публикације и информације о финансирању аутоматски одређује рачунарски програм